Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis

Hepatic hydrothorax occurs in 4-12% of patients with liver cirrhosis, A part of patients with persisted hydrothorax resists conservative treatment, known as refractory hepatic hydrothorax (RHH). Portal vein thrombosis (PVT) is observed in about 2.1 16.2% patients with liver cirrhosis, which may aggr...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 130; no. 16; pp. 1999 - 2000
Main Authors Zhang, Lin-Hao, Tong, Huan, Wei, Bo, Wu, Hao, Tang, Cheng-Wei
Format Journal Article
LanguageEnglish
Published China Medknow Publications and Media Pvt. Ltd 20.08.2017
Lippincott Williams & Wilkins Ovid Technologies
Medknow Publications & Media Pvt Ltd
Wolters Kluwer
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hepatic hydrothorax occurs in 4-12% of patients with liver cirrhosis, A part of patients with persisted hydrothorax resists conservative treatment, known as refractory hepatic hydrothorax (RHH). Portal vein thrombosis (PVT) is observed in about 2.1 16.2% patients with liver cirrhosis, which may aggravate portal hypertension.
Bibliography:11-2154/R
Hepatic hydrothorax occurs in 4-12% of patients with liver cirrhosis, A part of patients with persisted hydrothorax resists conservative treatment, known as refractory hepatic hydrothorax (RHH). Portal vein thrombosis (PVT) is observed in about 2.1 16.2% patients with liver cirrhosis, which may aggravate portal hypertension.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0366-6999
2542-5641
DOI:10.4103/0366-6999.211887